SPANLASTICS: A Unique Formulation Strategy in The Delivery of Pharmaceuticals-Carbapenems as a Model.

Abstract

Drug delivery systems based on nanotechnology have been significant in surpassing the challenges associated with traditional dose forms. A promising drug delivery vehicle is spanlastics, an elastic nanovesicle that can transport a variety of drug compounds. Spanlastics have shown an increasing amount of interest in various forms of administrative pathways. They may squeeze themselves through skin pores because they are elastic and malleable, making them ideal for transdermal delivery. Non-ionic surfactants or mixtures of surfactants make up spanlastics. Numerous studies have demonstrated how spanlastics greatly improve drug toxicity, drug bioavailability, and therapeutic efficacy. Our future goal is to evaluate the spanlastic-encapsulated carbapenem's antibacterial and anti-biofilm characteristics. Following the isolation of Staphylococcus epidermidis isolates and the assessment of their microbiological sensitivity, the plate microtiter test was employed to investigate their capacity to form biofilms.